Overexpression of Orphan Receptor Tyrosine Kinase <i>Ror1</i> as a Putative Tumor-Associated Antigen in Iranian Patients with Acute Lymphoblastic Leukemia
Mahdi Shabani(Shiraz University of Medical Sciences), Fazel Shokri(Tehran University of Medical Sciences), Hossein Asgarian‐Omran(University of Tehran), Gholam R. Toughe(University of Tehran), Håkan Mellstedt(Karolinska Institutet), Mahmood Jeddi‐Tehrani, Jalal Khoshnoodi(University of Tehran), Azam Roohi(University of Tehran), Hodjatallah Rabbani(Biotechnology Research Center), Narjes Tavoosi(Biotechnology Research Center), Parvaneh Vossough(Iran University of Medical Sciences), Mahin Kordmahin(University of Tehran), Ramazan Ali Sharifian(University of Tehran), Mohammad Faranoush(Iran University of Medical Sciences)
Cited by 46
Related Papers
The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
|PLoS ONE|2013|60
Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
|PLoS ONE|2013|58
Expression profile of orphan receptor tyrosine kinase (<i>ROR1</i>) and Wilms' tumor gene 1 (<i>WT1</i>) in different subsets of B-cell acute lymphoblastic leukemia
|Leukemia & lymphoma/Leukemia and lymphoma|2008|46
The Prognostic Value of Thrombocytopenia in COVID-19 Patients; a Systematic Review and Meta-Analysis.
|PubMed|2020|45
Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin
|Biomedicine & Pharmacotherapy|2017|31